Variables | Den-infected non-ICU controls (n = 108) | %/(IQR) | Den-infected ICU cases (n = 27) | %/(IQR) | COR | P-value | 95% CI | ACOR* | P-value | 95% CI |
---|---|---|---|---|---|---|---|---|---|---|
Hypoproteinemia | ||||||||||
Yes | 23 | 21 | 10 | 37 | 2.28 | 0.085 | 0.89–5.85 | 4.65 | 0.037 | 1.09–19.74 |
Hypotension | ||||||||||
Yes | 4 | 3.7 | 7 | 26 | 8.62 | 0.002 | 2.21–33.63 | 7.63 | 0.005 | 1.83–31.79 |
Severe organ involvement | ||||||||||
Yes | 1 | 0.9 | 10 | 37 | 40 | <0.001 | 5.12–312.5 | 33.04 | 0.003 | 3.30–331.3 |
Hematocrit change ≥20% concurrent with platelet <50 K | ||||||||||
Yes | 7 | 6.5 | 11 | 41 | 9.4 | <0.001 | 2.95–29.83 | 8.66 | 0.001 | 2.46–30.53 |
Systolic blood pressure | 105 | (100–114) | 110 | (91.5–118.5) | 0.98 | 0.216 | 0.96–1.01 | 0.97 | 0.046 | 0.94–0.99 |
Pulse rate | 90 | (80–96) | 95.5 | (88.5–102) | 1.03 | 0.049 | 1.00–1.07 | 1.05 | 0.012 | 1.01–1.09 |
Proportion neutrophils | 60.3 | (46.2–70.4) | 76.8 | (70.7–81.5) | 1.11 | <0.001 | 1.05–1.18 | 1.11 | 0.001 | 1.04–1.17 |
Proportion lymphocytes | 30.3 | (22–39) | 16.5 | (9.8–19.9) | 0.90 | <0.001 | 0.85–0.95 | 0.90 | 0.001 | 0.85–0.96 |
Proportion monocytes | 12.5 | (8.9–17.3) | 7.9 | (5.1–9.9) | 0.84 | 0.002 | 0.76–0.94 | 0.86 | 0.004 | 0.77–0.95 |
Platelet | 68 | (44–84) | 42.5 | (20.3–74.8) | 0.98 | 0.01 | 0.96–0.99 | 0.98 | 0.017 | 0.96–0.99 |
Serum urea | 3.5 | (2.6–4.6) | 5.1 | (3.7–6.8) | 1.33 | 0.002 | 1.11–1.58 | 1.26 | 0.030 | 1.02–1.56 |
Serum creatinine | 77 | (65–88.3) | 102 | (82.3–130) | 1.03 | 0.001 | 1.01–1.04 | 1.02 | 0.006 | 1.01–1.04 |
Serum AST | 114 | (70–195) | 156.5 | (96.5–516) | 1.01 | 0.017 | 1.00–1.04 | 1.01 | 0.019 | 1.00–1.04 |
Serum ALT | 74 | (38–121) | 92 | (55.8–293.3) | 1.01 | 0.012 | 1.001–1.06 | 1.01 | 0.017 | 1.001–1.06 |
Serum protein | 67 | (63–72) | 66 | (60.5–68.5) | 0.89 | 0.016 | 0.79–0.98 | 0.88 | 0.022 | 0.79–0.98 |
Serum albumin | 37 | (35–40) | 37 | (31–39) | 0.8 | 0.004 | 0.69–0.93 | 0.81 | 0.006 | 0.70–0.94 |